Adults aged 50 to 77 in England, in a randomized trial
“Stage III/IV cancer incidence rate did not differ significantly between intervention and control arms (IRR: 1.03 [0.92-1.14], p=0.63).”
N Engl J Med, 2026 · controlled trial · PMID 42776074
Episode check · Lifestyle and genes
Is cancer increasing?
Cancer blood tests for everyone won't cut deaths, the episode says. Ten studies are mixed on it.
We checked six claims from a 125-minute episode on cancer against 87 studies. The studies are mixed on the lead, that blood tests for many cancers, used on everyone, are unlikely to cut cancer deaths. The one large trial found no fewer late-stage cancers. Four computer models project fewer deaths. No trial has reported deaths yet. The studies agree that these tests bring false alarms and extra tests. Three claims have strong support: obesity raises the risk of endometrial cancer, US cancer death rates are falling, and colorectal cancer is rising in young adults. The studies conflict on fiber and colorectal cancer, and on whether keeping your thymus means less cancer. A BRCA1 mutation raises breast cancer risk, though most studies put the early-age risk far higher than said. The chapters we did not check are in grey.
The source we checked
On YouTube as of Oct 27, 2026
“412 ‒ The evolving science of cancer: emerging approaches to prevention and early detection, & more”
21 chapters · 6 claims checked against 87 studies · 17 chapters not checked yet · checked Oct 27, 2026 Watch on YouTube →
What changed in 15 years of cancer care Lead finding
Does obesity raise endometrial cancer risk?
“We know almost with great certainty that obesity is a risk factor for certain kinds of cancers, endometrial being one of them.”
Siddhartha Mukherjee, a guest on this episode.
What 10 studies found
Strong consensus for
10 agree
All ten studies agree. Endometrial cancer is cancer of the lining of the womb. In UK adults, each 5-point rise in BMI went with a large rise in the risk of cancer of the womb. In 33,436 women past menopause, those with a BMI of 35 or more had 4.70 times the risk of women at a healthy weight. One study of UK women estimated that about half of these cancers after menopause come from overweight or obesity. Genetic studies, which help rule out other causes, point the same way.
Computed from 10 studies that test this point, each judged by two readers, in full. 10 more studies are waiting for a full read and do not count yet.
Every study and its exact wordsAre cancer deaths falling while colorectal cancer rises in young adults?
“So, we are actually making progress. The idea that cancer is exploding and and killing everyone in the population is nonsense. But, but, there's a very important but, we know that colorectal cancer is on the rise in young people.”
Siddhartha Mukherjee, a guest on this episode.
What 10 studies found
Strong consensus for
10 agree
All ten studies agree. These are national reports built from every US death certificate. Cancer death rates fell 34% from 1991 to 2022, and the latest report counts 4.8 million deaths avoided since 1991. The reports credit less smoking, earlier detection and better treatment.
Computed from 10 studies that test this point, each judged by two readers, in full. 10 more studies are waiting for a full read and do not count yet.
Every study and its exact words“we know that colorectal cancer is on the rise in young people.”
What 10 studies found
Strong consensus for
10 agree
All ten studies agree. In the US, colon cancer in adults aged 20 to 39 has risen by 1.0% to 2.4% a year since the mid-1980s. Registries in Europe, Australia and Canada show the same rise in people under 50. A study of many countries found early-onset colorectal cancer rising in 27 countries and steady in 23.
Computed from 10 studies that test this point, each judged by two readers, in full. 10 more studies are waiting for a full read and do not count yet.
Every study and its exact wordsIs a Galleri test unlikely to help people at average risk?
“at least for now, we know that if you just take those tests and unloosen them on a general population. So, without selecting for high-risk people, without selecting for people who have had cancer before um we know that those tests are probably not going to work.”
Siddhartha Mukherjee, a guest on this episode.
What 10 studies found
Mixed
2 agree · 4 partly agree · 4 disagree
Two of ten studies agree. The NHS-Galleri trial tested adults aged 50 to 77 in England: late-stage cancers were no less common in the tested group. Four disagree, but all four are computer models, not tests on real people. One projects 17 to 21% fewer cancer deaths. Two of the models were paid for by the test's maker. Four are mixed. A review found no results yet on deaths, and no trial here has reported them.
Computed from 10 studies that test this point, each judged by two readers, in full. 10 more studies are waiting for a full read and do not count yet.
Every study and its exact words“They're going to lead to false positives, they're going to lead to extra biopsies and extra um you know, tests more tests following tests etc. But those are not going to decrease um are unlikely to decrease the um mortality from cancers.”
What 10 studies found
Strong consensus for
7 agree · 3 partly agree
Seven of ten studies agree. In women aged 65 to 75, 1.0% had a PET-CT scan after a false alarm and 0.22% had an invasive test for nothing. In a large US and Canadian study, 46.3% of people with a false alarm had invasive procedures. Three are mixed. In the NHS-Galleri trial in England, the false-alarm rate was 0.45%, lower than for some single-cancer screening tests.
Computed from 10 studies that test this point, each judged by two readers, in full. 3 more studies are waiting for a full read and do not count yet.
Every study and its exact wordsCloser look
Look at what they tested
A computer model of people aged 50 to 79 in England
“The reduction in five-year cancer mortality was between 1787 and 2257 per 100,000 persons in the screening programme (between 17 and 21%) in the fast dwell time scenario with HR = 3 and slow dwell time scenario with HR = 1, respectively.”
Br J Cancer, 2023 · other primary study · PMID 37185463
A computer model of US adults, paid for by the test's maker
“Table 4 shows that the relative reduction of cancer-specific mortality reached 13%–16% for all dwell time scenarios at year 5 for three rounds of annual MCED screening, and 16%–19% at year 7 for five rounds of annual MCED screening.”
J Med Screen, 2024 · other primary study · PMID 38304990
A review of the studies of these tests so far
“No meaningful results were reported relating to patient-relevant outcomes, such as mortality, potential harms, HRQoL, acceptability or satisfaction.”
Health Technol Assess, 2025 · systematic review · PMID 39898371
Inherited genes and bad luck
Does a BRCA1 mutation mean a tenfold breast cancer risk?
“BRCA1 is a shove mutation. It shoves you off the cliff and puts you at a ninefold, tenfold risk above the normal population to get hereditary breast cancer at an early age.”
Siddhartha Mukherjee, a guest on this episode.
What 9 studies found
Leaning for
2 agree · 7 partly agree
Every study finds a large rise in risk. Two of nine agree with the size said, both across all ages: odds ratios up to 10.57 across high-risk genes, and 7.62 for BRCA1. Seven are mixed, and most of them put the early-age risk much higher. One found a relative risk of 33 at ages 30 to 39. In Malaysia and Singapore it was about 25 before age 30. The risk falls with age.
Computed from 9 studies that test this point, each judged by two readers, in full. 10 more studies are waiting for a full read and do not count yet.
Every study and its exact words“that still only covers um a fraction, about a third, maybe a fourth, of hereditary breast cancer.”
What 10 studies found
Leaning for
2 agree · 8 partly agree
Two of ten studies agree: known genes explain less than 25% of family risk, and many genes of small effect may explain the rest. Eight are mixed. The common variants found so far explain only about 18% of family risk, and all common variants together at best about 41%. Much of family risk is still unexplained.
Computed from 10 studies that test this point, each judged by two readers, in full. 4 more studies are waiting for a full read and do not count yet.
Every study and its exact wordsInflammation wakes sleeper cells
26:40 “You had a particular kind of inflammatory response in your body and your 2,000 in one of your 2,000 cells which already was carrying a mutation turned from a sleeper cell, a dormant cell” Said on tape, not checked yet.
Small genetic nudges add up
29:37 “Because if I could figure out, you know, where you are in the nudge versus shove cascade, I could tell you I could quantify your risk.” Said on tape, not checked yet.
Insulin, obesity and cancer
32:27 “It is the insulin and it's the cascade of insulin and what follows the insulin cascade that is responsible at least for the resistance of cancer cells to therapy.” Said on tape, not checked yet.
Osteoarthritis and cartilage stem cells
41:00 “I never believed that osteoarthritis was an obesity disease.” Said on tape, not checked yet.
Why T cells miss cancer
55:39 “And that's because all of our cells are carrying not one flag, not two flags, but dozens of flags saying to a B cell and T cell, "I'm normal. Don't eat me.” Said on tape, not checked yet.
The thymus and disease risk
Does keeping your thymus mean less cancer and autoimmune disease?
“People who had an intact thymus tended to have less diseases such as autoimmune disease in and cancer. People who lost their thymus as they grew older, because the thymus naturally involutes and dies, tended to have more.”
Siddhartha Mukherjee, a guest on this episode.
What 6 studies found
Conflicting
3 agree · 1 partly agree · 2 disagree
The thymus is a small organ in the chest that trains immune cells. It shrinks with age. Three of six studies agree. In a lung-screening trial, people whose CT scans showed a healthier thymus got lung cancer less often: 3.4% against 5.3% over 6 years. In Boston, people who had the thymus removed got cancer more often within 5 years, 7.4% against 3.7%. Two studies disagree: in Toronto and in Israel, removal made no difference to later cancer. One is mixed.
Computed from 6 studies that test this point, each judged by two readers, in full. Sources land on both sides. 6 more studies are waiting for a full read and do not count yet.
Every study and its exact words“People who had an intact thymus tended to have less diseases such as autoimmune disease in and cancer. People who lost their thymus as they grew older, because the thymus naturally involutes and dies, tended to have more.”
What 8 studies found
Leaning for
1 agree · 6 partly agree · 1 disagree
Only one of eight studies agrees. In Taiwan, autoimmune disease was 2.68 times as common after the thymus was removed. One disagrees: an Israeli study found no difference over 10 years. Six are mixed. In the Boston study, the higher risk faded when people were followed for 20 years. The CT study described on the episode did not measure autoimmune disease.
Computed from 8 studies that test this point, each judged by two readers, in full. 7 more studies are waiting for a full read and do not count yet.
Every study and its exact wordsCloser look
The scan study tested lung cancer in smokers
The CT study described on the episode found that a healthier thymus went with less lung cancer in older heavy smokers. It did not measure autoimmune disease.
CAR-T cells and whole cell lines
1:08:00 “So, the CAR-T cells that kill B cell leukemias and lymphomas don't just kill B cell leukemias and lymphomas. They kill all B cells.” Said on tape, not checked yet.
Where a pancreatic tumor sits
1:14:36 “The tail ones tend to be detected incidentally. The head ones tend to be detected with pain and jaundice and other things.” Said on tape, not checked yet.
Surgery first, then drugs
1:16:43 “cancer therapy almost always begins with therapy directed against diffuse metastatic cancer.” Said on tape, not checked yet.
Colorectal cancer in young adults
Does doubling your fiber lower colorectal cancer risk?
“So, my recommendation for people who want to avoid colorectal cancer is triple or double your fiber intake.”
Siddhartha Mukherjee, a guest on this episode.
What 10 studies found
Conflicting
3 agree · 3 partly agree · 4 disagree
The studies split. Four of ten disagree. Among 88,757 nurses, women who ate the most fiber, 28.5 g a day, had the same risk as women who ate the least, 8.5 g. A pooled analysis of 13 cohort studies found no link. A pooled analysis adds up the results of many smaller studies. Three agree. Across ten European countries, each extra 10 g of fiber a day went with lower risk. In UK groups, people eating about 24 g a day had 30% lower odds than people eating 10 g. Three are mixed. No study had people double or triple their fiber on purpose.
Computed from 10 studies that test this point, each judged by two readers, in full. Sources land on both sides. 10 more studies are waiting for a full read and do not count yet.
Every study and its exact wordsCloser look
What the paper behind the advice found
The old paper the episode describes found colorectal cancer rare in rural Africa, where people ate a high-fiber diet. It did not find it absent, and it said the link with cancer was not yet shown to be a cause. No study here had people double or triple their fiber.
AI that designs drugs
1:30:43 “the good news is that you can teach an AI all those rules.” Said on tape, not checked yet.
Cancer prevention in 15 years
1:35:07 “So, the answer is always going to be prevention.” Said on tape, not checked yet.
Health instead of disease
1:38:32 “The prevention of pathological disease cancer, heart disease, the two biggest killers is not the answer to the prolongation of longevity.” Said on tape, not checked yet.
Heart disease versus cancer
1:41:43 “you can you can take aspirin and Lipitor and you know PCSK9 you can take like 17 drugs now.” Said on tape, not checked yet.
What the oldest people die of
1:43:00 “they don't die of cancer. What they're dying of is failure of skin regeneration, their skin falls off.” Said on tape, not checked yet.
No shortcut to a longer life
1:49:11 “The hack but the hack is not just a simple hack. It's not going to be peptides It's going to be finding out systematically how to address these regenerative failures” Said on tape, not checked yet.
Biomarkers of aging
1:53:06 “The problem with finding me a reliable biomarker is going to is is that the biomarker study itself will take 15, 20, 30 years” Said on tape, not checked yet.
Drugs aimed at cancer metabolism
1:57:59 “basically the idea that cancer cells must depend on particular metabolic inputs, which make them different from normal cells.” Said on tape, not checked yet.
How the books get written
2:03:47 “My writing is actually short. And my editing is not.” Said on tape, not checked yet.
How we checked this episode
We go through the episode chapter by chapter and pull out each claim. For every claim we can test, two readers read each study in full and mark whether it agrees, partly agrees or disagrees. A fixed rule turns those marks into the badge, the same rule Precis uses on every page. Nobody writes or edits a badge. Chapters we haven't checked are shown in grey, so you can see everything the episode said.
Every quote is 20 seconds or less and opens the episode at that second. This is not medical advice. Talk to your doctor before you change anything.